…in a notice set to be published in the Federal Register on Wednesday [Jan. 3, 2024], DEA said it received comments from registered manufacturers requesting increases to previously proposed 2024 quotas for the Schedule I substances in order to “meet medical and scientific needs,” and it agreed to do so in the new final order. Accordingly, the agency nearly doubled the quotas for delta-9 THC and all other tetrahydrocannabinol… DEA is also calling for 20,000 grams of psilocybin (up from an initially proposed 15,000 grams) and 11,000 grams of DMT (up from 3,000 grams).

“DEA has received and subsequently approved new registration applications for schedule I researchers and new applications for registration from manufacturers to grow, synthesize, extract, and prepare dosage forms containing specific schedule I hallucinogenic substances for research and clinical trial purposes.” In the new document, DEA also responded to comments requesting increases to psychedelic production quotas for “religious use” and expressing frustration that the agency has “disregarded their legal religious use of psychedelics as a factor when setting the production quotas of these substances.” The commenters asked for a hearing with the DEA administrator to discuss the issue, but the agency did not directly address that request.

Original Article (Marijuana Moment):
DEA calls for even more THC, psilocybin and DMT to be produced for research in 2024
Artwork Fair Use: thomson200